Northeast Pharmaceutical Group Co., Ltd.
000597.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$7.01B
Close$
Share Statistics
| Market cap | $7.01 Billion |
|---|---|
| Enterprise Value | $7.60 Billion |
| Dividend Yield | $0.06 (1.12%) |
| Earnings per Share | $0.18 |
| Beta | 0.06 |
| Outstanding Shares | 1,426,928,265 |
Return
| Return on Equity | 3.88% |
|---|---|
| Return on Assets | 1.58% |
| Return on Invested Capital | 4.01% |
Valuation & Multiples
| P/E Ratio | 32.54 |
|---|---|
| PEG | -84.81 |
| Price to Sales | 1.19 |
| Price to Book Ratio | 1.59 |
| Enterprise Value to Revenue | 1.16 |
| Enterprise Value to EBIT | 30.64 |
| Enterprise Value to Net Income | 35 |
| Total Debt to Enterprise | 0.6 |
| Debt to Equity | 0.82 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Northeast Pharmaceutical Group Co., Ltd.
5,727 employees
CEO: Yonggang Cai Northeast Pharmaceutical Group Co., Ltd., established in 1993 and headquartered in Shenyang, China, is a key manufacturer and supplier of active pharmaceutical ingredients (APIs) derived from both chemical synthesis and bio-fermentation....